Trupanion, Inc. $TRUP Shares Sold by Greenlea Lane Capital Management LLC

Key Points

• Greenlea Lane Capital Management LLC reduced its holdings in Trupanion, Inc. by 2.8%, bringing its ownership to approximately $33.84 million across 907,835 shares, which represents about 11.7% of its investment portfolio.
• JPMorgan Chase & Co. increased its position in Trupanion by a staggering 458.3% during the fourth quarter, acquiring an additional 129,782 shares worth $7.62 million.
• Trupanion reported earnings of $0.22 per share for the quarter, exceeding analysts’ expectations, alongside a 12.3% year-over-year revenue growth totaling $353.56 million.

Greenlea Lane Capital Management LLC lowered its position in shares of Trupanion, Inc. (NASDAQ:TRUP - Free Report) by 2.8% in the first quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 907,835 shares of the financial services provider's stock after selling 25,820 shares during the quarter. Trupanion accounts for 11.7% of Greenlea Lane Capital Management LLC's investment portfolio, making the stock its 5th largest holding. Greenlea Lane Capital Management LLC owned 2.12% of Trupanion worth $33,835,000 at the end of the most recent reporting period.

Other large investors also recently bought and sold shares of the company. Balyasny Asset Management L.P. increased its holdings in Trupanion by 368.2% during the 4th quarter. Balyasny Asset Management L.P. now owns 841,254 shares of the financial services provider's stock valued at $40,548,000 after acquiring an additional 661,559 shares in the last quarter. BNP Paribas Financial Markets increased its holdings in Trupanion by 170.7% during the 4th quarter. BNP Paribas Financial Markets now owns 337,093 shares of the financial services provider's stock valued at $16,248,000 after acquiring an additional 212,545 shares in the last quarter. Hosking Partners LLP increased its holdings in Trupanion by 86.9% during the 1st quarter. Hosking Partners LLP now owns 397,656 shares of the financial services provider's stock valued at $14,821,000 after acquiring an additional 184,936 shares in the last quarter. Freestone Grove Partners LP purchased a new position in Trupanion during the 4th quarter valued at about $7,776,000. Finally, First Trust Advisors LP purchased a new position in Trupanion during the 4th quarter valued at about $7,083,000.

Trupanion Stock Down 0.0%

Shares of NASDAQ TRUP traded down $0.02 during trading on Monday, reaching $48.59. 513,255 shares of the stock were exchanged, compared to its average volume of 558,730. The business's 50-day moving average price is $51.21 and its 200 day moving average price is $44.02. Trupanion, Inc. has a twelve month low of $31.00 and a twelve month high of $57.90. The company has a quick ratio of 1.69, a current ratio of 1.69 and a debt-to-equity ratio of 0.32. The company has a market capitalization of $2.09 billion, a price-to-earnings ratio of 186.89 and a beta of 1.78.

Trupanion (NASDAQ:TRUP - Get Free Report) last posted its earnings results on Thursday, August 7th. The financial services provider reported $0.22 EPS for the quarter, topping analysts' consensus estimates of ($0.03) by $0.25. Trupanion had a net margin of 0.81% and a return on equity of 3.31%. The business had revenue of $353.56 million for the quarter, compared to analysts' expectations of $346.73 million. During the same period in the previous year, the company posted ($0.14) earnings per share. The business's revenue for the quarter was up 12.3% compared to the same quarter last year. As a group, equities analysts forecast that Trupanion, Inc. will post 0.13 EPS for the current fiscal year.

Insider Transactions at Trupanion

In related news, CFO Fawwad Qureshi sold 2,534 shares of Trupanion stock in a transaction on Thursday, May 29th. The shares were sold at an average price of $48.31, for a total value of $122,417.54. Following the completion of the sale, the chief financial officer owned 3,545 shares in the company, valued at approximately $171,258.95. The trade was a 41.68% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. Also, CEO Margaret Tooth sold 4,000 shares of Trupanion stock in a transaction on Tuesday, May 20th. The stock was sold at an average price of $45.86, for a total transaction of $183,440.00. Following the completion of the sale, the chief executive officer owned 118,784 shares of the company's stock, valued at approximately $5,447,434.24. This trade represents a 3.26% decrease in their position. The disclosure for this sale can be found here. Over the last three months, insiders have sold 11,562 shares of company stock valued at $544,870. Corporate insiders own 5.42% of the company's stock.

Wall Street Analysts Forecast Growth

TRUP has been the topic of several analyst reports. Cantor Fitzgerald raised shares of Trupanion to a "hold" rating in a research note on Wednesday, August 13th. Stifel Nicolaus raised their price target on shares of Trupanion from $41.00 to $45.00 and gave the stock a "hold" rating in a research note on Friday, August 8th. Lake Street Capital decreased their price target on shares of Trupanion from $65.00 to $60.00 and set a "buy" rating on the stock in a research note on Friday, May 2nd. Finally, Piper Sandler raised their target price on shares of Trupanion from $62.00 to $67.00 and gave the stock an "overweight" rating in a research report on Friday, August 8th. Three equities research analysts have rated the stock with a hold rating and three have issued a buy rating to the company's stock. Based on data from MarketBeat.com, the stock has a consensus rating of "Moderate Buy" and a consensus target price of $54.17.

Trupanion Company Profile

Trupanion, Inc, together with its subsidiaries, provides medical insurance for cats and dogs on a monthly subscription basis in the United States, Canada, Continental Europe, and Australia. The company operates in two segments, Subscription Business and Other Business. It serves pet owners and veterinarians.